Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Gibson

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|August 3, 2021
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?Claudia Schmidt, Tomer Babu, Hana Kostrhunova, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 20, 2008
Peculiar mechanistic and structural features of the carboplatin-cytochrome c system revealed by ESI-MS analysisChiara Gabbiani, Angela Casini, Guido Mastrobuoni, et al.
Scientific Reports|June 18, 2017
Epigenetic and antitumor effects of platinum(IV)-octanoato conjugatesVojtech Novohradsky, Ilaria Zanellato, Cristina Marzano, et al.
Optics Letters|October 30, 2015
Low-loss, robust fusion splicing of silica to chalcogenide fiber for integrated mid-infrared laser technology developmentRajesh Thapa, Rafael R Gattass, Vinh Nguyen, et al.
Dalton Transactions (Cambridge, England : 2003)|May 18, 2017
Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(iv) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]Benjamin W J Harper, Emanuele Petruzzella, Roman Sirota, et al.
Angewandte Chemie (International Ed. in English)|August 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell DeathAmrita Sarkar, Vojtech Novohradsky, Moumita Maji, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2005
Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligandYousef Najajreh, Dmitri Prilutski, Yael Ardeli-Tzaraf, et al.
Journal of Medicinal Chemistry|July 21, 2006
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studiesYousef Najajreh, Elena Khazanov, Seba Jawbry, et al.
Chemistry & Biodiversity|August 26, 2022
Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological ActivityXiao Liu, Marie-Christin Barth, Klaudia Cseh, et al.
Dalton Transactions (Cambridge, England : 2003)|October 3, 2022
Novel oxaliplatin(IV) complexes conjugated with ligands bearing pendant 1,2-dithiolane/1,2-diselenolane/cyclopentyl motifsXiao Liu, Dominik Wenisch, Marie-Christin Barth, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|August 3, 2021
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?Claudia Schmidt, Tomer Babu, Hana Kostrhunova, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 20, 2008
Peculiar mechanistic and structural features of the carboplatin-cytochrome c system revealed by ESI-MS analysisChiara Gabbiani, Angela Casini, Guido Mastrobuoni, et al.
Scientific Reports|June 18, 2017
Epigenetic and antitumor effects of platinum(IV)-octanoato conjugatesVojtech Novohradsky, Ilaria Zanellato, Cristina Marzano, et al.
Optics Letters|October 30, 2015
Low-loss, robust fusion splicing of silica to chalcogenide fiber for integrated mid-infrared laser technology developmentRajesh Thapa, Rafael R Gattass, Vinh Nguyen, et al.
Dalton Transactions (Cambridge, England : 2003)|May 18, 2017
Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(iv) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]Benjamin W J Harper, Emanuele Petruzzella, Roman Sirota, et al.
Angewandte Chemie (International Ed. in English)|August 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell DeathAmrita Sarkar, Vojtech Novohradsky, Moumita Maji, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2005
Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligandYousef Najajreh, Dmitri Prilutski, Yael Ardeli-Tzaraf, et al.
Journal of Medicinal Chemistry|July 21, 2006
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studiesYousef Najajreh, Elena Khazanov, Seba Jawbry, et al.
Chemistry & Biodiversity|August 26, 2022
Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological ActivityXiao Liu, Marie-Christin Barth, Klaudia Cseh, et al.
Dalton Transactions (Cambridge, England : 2003)|October 3, 2022
Novel oxaliplatin(IV) complexes conjugated with ligands bearing pendant 1,2-dithiolane/1,2-diselenolane/cyclopentyl motifsXiao Liu, Dominik Wenisch, Marie-Christin Barth, et al.
Pageof 9